Haynes Lab: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 12: | Line 12: | ||
<div style="padding-left: 5px; padding-right: 80px; float: left; text-align: justify; width: 600px; height: 800px"> | <div style="padding-left: 5px; padding-right: 80px; float: left; text-align: justify; width: 600px; height: 800px"> | ||
Our group uses synthetic, systems, and quantitative biology to engineer useful gene and protein-based biological devices and to deepen our understanding of molecular cell biology. We operate biological devices primarily in human/ mammalian cells. Accelerating the pace of | Our group uses synthetic, systems, and quantitative biology to engineer useful gene and protein-based biological devices and to deepen our understanding of molecular cell biology. We operate biological devices primarily in human/ mammalian cells. Accelerating the pace of therapeutic technologies (such as tissue regeneration and customizable protein-based drugs) via modular design is the grand challenge that shapes our research plans. | ||
</div> | |||
<div style="padding-left: 5px; padding-right: 80px; float: left; text-align: justify; width: 600px; height: 800px"> | |||
CURRENT PROJECTS<br> | |||
* '''Synthetic chromatin for human cell differentiation''' - Behzad Damadzadeh | |||
* '''Microbial communication with synthetic quorum sensing''' - Rene Davis | |||
* '''Engineering epigenetic transcription factors''' - Brady Laughlin (FURI) | |||
* '''Protein-DNA fusions in living microbes''' - Ryan Muller (SOLUR) | |||
* '''Synthetic chromatin and UV-damage''' - Brendan Fries | |||
</div> | </div> | ||
Revision as of 17:18, 21 September 2013
Our group uses synthetic, systems, and quantitative biology to engineer useful gene and protein-based biological devices and to deepen our understanding of molecular cell biology. We operate biological devices primarily in human/ mammalian cells. Accelerating the pace of therapeutic technologies (such as tissue regeneration and customizable protein-based drugs) via modular design is the grand challenge that shapes our research plans.
CURRENT PROJECTS
- Synthetic chromatin for human cell differentiation - Behzad Damadzadeh
- Microbial communication with synthetic quorum sensing - Rene Davis
- Engineering epigenetic transcription factors - Brady Laughlin (FURI)
- Protein-DNA fusions in living microbes - Ryan Muller (SOLUR)
- Synthetic chromatin and UV-damage - Brendan Fries
Lab Notebooks
